Tribune Therapeutics
Tribune Therapeutics is a developer of therapeutics for fibrotic diseases founded in 2020 by Georg Vo Beiske, Ole Joergen and Havard Attramadal.
1
Funding Rounds
$40.0m
Money raised
Overview
Tribune Therapeutics is a developer of therapeutics for fibrotic diseases founded in 2020 by Georg Vo Beiske, Ole Joergen and Havard Attramadal.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ge*** Vo Be**** |
|
- | |
| Ol* Jo***** |
|
- | |
| Ha**** At******** | - | - | - |
Funding series
Funding Series Analysis
The company Tribune Therapeutics has raised a total of $40m in funding over 1 rounds.
Key Insights:
- Tribune Therapeutics Series A Round, March 2025: $40m
Tribune Therapeutics Series A Round, March 2025
$40m
Industries
Tribune Therapeutics is active in the following industries: